NASDAQ · Biotechnology

LONA (LONA) Stock

$7.47 +5.81% NASDAQ: LONA Healthcare

Valuation

MetricValue
Price$7.47
Market Cap$29.46M
P/E Ratio-0.34
P/B Ratio2.83
P/S Ratio0.00
EPS (TTM)$-24.70
52-Week High$11.91
52-Week Low$4.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-298.76%
ROA-46.46%
ROCE-364.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio1.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-64.0M$-104.0M$-125.0M$-101.0M$-102.0M
Net Profit$-55.0M$-96.0M$-118.0M$-97.0M$-106.0M
EPS$-14.90$-25.30$-30.90$-25.20$-24.70
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$332.0M$258.0M$160.0M$59.0M$92.0M
Total Liabilities$11.0M$23.0M$30.0M$14.0M$64.0M
Cash$111.0M$96.0M$91.0M$48.0M$69.0M
Borrowings$2.0M$2.0M$2.0M$1.0M$1.0M

Latest News

Immuneering Names Andrew Gengos as CFO MT Newswires · Jun 15, 2026 LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit GlobeNewswire · Jun 4, 2026 LeonaBio to Participate in Upcoming Medical and Industry Meetings in June GlobeNewswire · May 27, 2026 LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire · May 7, 2026 LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. GlobeNewswire · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-43.0M$-72.0M$-101.0M$-97.0M$-46.0M
Investing Cash Flow$-6.0M$57.0M$95.0M$55.0M$-16.0M
Financing Cash Flow$0$0$0$0$82.0M
Net Cash Flow$50.0M$-15.0M$-5.0M$-42.0M$21.0M
Free Cash Flow$-45.0M$-74.0M$-101.0M$-97.0M$-46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-0.27
FCF Yield-155.01%
Quick Ratio10.38
Interest Coverage—
Return 1Y127.27%
Return 3Y-70.68%
Return 5Y-90.55%

Ownership

Insiders Held4.51%
Institutions Held70.41%
Institutions Float Held73.74%
Institutional HolderSharesReport Date
Perceptive Advisors Llc1,859,3222026-03-31
Adar1 Capital Management, LLC 727,4812026-03-31
Acorn Capital Advisors, LLC 634,5392026-03-31
Commodore Capital Lp464,3982026-03-31
NEA Management Company, LLC464,3982026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
APLMApollomics, Inc. $18.76 +2.99% -2.41 $20.69M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%
CTXR $0.57 -9.81% -0.68 $6.37M 0.00%
DARE $1.32 +3.13% -1.94 $12.57M 0.00%

About LONA

LONA is led by CEO Mark J. Litton, employs 26 people, headquartered in US, publicly traded since 2020.

LONA stock trades at $7.47 with a market capitalization of $29.46M. The stock is valued at a price-to-earnings (P/E) ratio of -0.34, price-to-book of 2.83, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.25 and $11.91, and currently trades 37.3% below its 52-week high.

On profitability, LONA generates a return on equity (ROE) of -298.76%, return on capital employed of -364.29%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides